SI0925069T1 - Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer - Google Patents

Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer

Info

Publication number
SI0925069T1
SI0925069T1 SI9730769T SI9730769T SI0925069T1 SI 0925069 T1 SI0925069 T1 SI 0925069T1 SI 9730769 T SI9730769 T SI 9730769T SI 9730769 T SI9730769 T SI 9730769T SI 0925069 T1 SI0925069 T1 SI 0925069T1
Authority
SI
Slovenia
Prior art keywords
cetrorelix
treatment
prostate
hypertrophy
prostate cancer
Prior art date
Application number
SI9730769T
Other languages
Slovenian (sl)
Inventor
Jurgen Engel
Thomas Reissmann
Hilde Riethmuller-Winzen
Jurgen Rawert
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Priority claimed from PCT/EP1997/004740 external-priority patent/WO1998010781A1/en
Publication of SI0925069T1 publication Critical patent/SI0925069T1/en

Links

SI9730769T 1996-09-12 1997-09-01 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer SI0925069T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2599096P 1996-09-12 1996-09-12
US4322897P 1997-04-10 1997-04-10
PCT/EP1997/004740 WO1998010781A1 (en) 1996-09-12 1997-09-01 Means for treating prostate hypertrophy and prostate cancer
EP97944818A EP0925069B1 (en) 1996-09-12 1997-09-01 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer

Publications (1)

Publication Number Publication Date
SI0925069T1 true SI0925069T1 (en) 2007-10-31

Family

ID=38654094

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730769T SI0925069T1 (en) 1996-09-12 1997-09-01 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer

Country Status (1)

Country Link
SI (1) SI0925069T1 (en)

Similar Documents

Publication Publication Date Title
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
SI0968208T1 (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
IL129356A0 (en) Conjugates useful in the treatment of prostate cancer
AU2235395A (en) Biological markers of benign prostate hyperplasia
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
AU4003597A (en) Methods of diagnosing and treating cancer
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
ZA983968B (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia.
ZA982819B (en) Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators.
EP0733365A3 (en) Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
SI0925069T1 (en) Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
EP0748627A3 (en) Melatonin agonists for use in the treatment of benign prostatic hyperplasia
ZA978162B (en) Means for treating prostate hypertrophy and prostate cancer.
AU4402497A (en) Methods and means for the treatment of malignancies
ZA979655B (en) Conjugates useful in the treatment of prostate cancer.
AU4046197A (en) Use of 5,6-dihydro-5-azacytidine in the treatment of prostate cancer
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
AUPO851597A0 (en) Treatment of prostate cancer
GB9617941D0 (en) New approach to the treatment of prostate cancer
GB9624170D0 (en) Conjugates useful in the treatment of prostate cancer